首页 > 最新文献

US endocrinology最新文献

英文 中文
Management Options for Infertile Women with Polycystic Ovary Syndrome 多囊卵巢综合征不孕妇女的治疗选择
Q4 Medicine Pub Date : 2018-01-01 DOI: 10.17925/USE.2018.14.2.67
G. Mariani, J. Bellver
Polycystic ovary syndrome (PCOS) is a heterogenous condition affecting 5–10% of women at reproductive age. It is the most common cause of anovulatory infertility, characterized by hyperandrogenism and arrested follicle development, and is frequently associated with metabolic features such as insulin resistance and obesity. The diagnosis of PCOS, based on the Rotterdam criteria (2003), can be made when at least two of the following three main features are met: oligo-ovulation and/or anovulation, hyperandrogenism (clinical and/or biochemical), and polycystic ovarian morphology at ultrasound examination. Several approaches to ovulation induction have been proposed in women with PCOS. These approaches vary in efficacy, treatment duration, cost, and patient compliance. Management includes lifestyle changes, pharmacotherapy (metformin, clomiphene citrate, letrozole, gonadotropins, inositol), laparoscopic surgery (ovarian drilling), and assisted reproductive techniques, usually in vitro fertilization (see Figure 1). Clinical decisions in PCOS anovulatory patients are currently supported by a recently published international evidence-based guideline that provides 166 recommendations to help clinicians in the diagnosis and management of PCOS and to guide clinical practice.
多囊卵巢综合征(PCOS)是一种异质性疾病,影响5-10%的育龄妇女。它是无排卵性不孕的最常见原因,其特征是雄激素分泌过多和卵泡发育受阻,并且经常与胰岛素抵抗和肥胖等代谢特征相关。根据鹿特丹标准(2003),当满足以下三个主要特征中的至少两个时,可以诊断多囊卵巢综合征:排卵少和/或无排卵,雄激素过多(临床和/或生化),超声检查多囊卵巢形态。对多囊卵巢综合征的妇女提出了几种诱导排卵的方法。这些方法在疗效、治疗时间、费用和患者依从性方面各不相同。治疗包括改变生活方式、药物治疗(二甲双胍、枸橼酸克罗米芬、来曲唑、促性腺激素、肌醇)、腹腔镜手术(卵巢钻孔)和辅助生殖技术。PCOS无排卵患者的临床决策目前得到最近发表的国际循证指南的支持,该指南提供了166条建议,以帮助临床医生诊断和管理PCOS,并指导临床实践。
{"title":"Management Options for Infertile Women with Polycystic Ovary Syndrome","authors":"G. Mariani, J. Bellver","doi":"10.17925/USE.2018.14.2.67","DOIUrl":"https://doi.org/10.17925/USE.2018.14.2.67","url":null,"abstract":"Polycystic ovary syndrome (PCOS) is a heterogenous condition affecting 5–10% of women at reproductive age. It is the most common cause of anovulatory infertility, characterized by hyperandrogenism and arrested follicle development, and is frequently associated with metabolic features such as insulin resistance and obesity. The diagnosis of PCOS, based on the Rotterdam criteria (2003), can be made when at least two of the following three main features are met: oligo-ovulation and/or anovulation, hyperandrogenism (clinical and/or biochemical), and polycystic ovarian morphology at ultrasound examination. Several approaches to ovulation induction have been proposed in women with PCOS. These approaches vary in efficacy, treatment duration, cost, and patient compliance. Management includes lifestyle changes, pharmacotherapy (metformin, clomiphene citrate, letrozole, gonadotropins, inositol), laparoscopic surgery (ovarian drilling), and assisted reproductive techniques, usually in vitro fertilization (see Figure 1). Clinical decisions in PCOS anovulatory patients are currently supported by a recently published international evidence-based guideline that provides 166 recommendations to help clinicians in the diagnosis and management of PCOS and to guide clinical practice.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Telemedicine Services for Emerging Adults with Type 1 Diabetes 新兴成人1型糖尿病患者的远程医疗服务
Q4 Medicine Pub Date : 2018-01-01 DOI: 10.17925/USE.2018.14.2.73
Neesha Ramchandani
Emerging adults with type 1 diabetes (T1D) often find it challenging to manage their diabetes well due to the many competing priorities they are juggling during this time. The majority of emerging adults (72%) are already looking for health information online, so telemedicine may be an avenue to explore with them. Telemedicine services for individuals with T1D are becoming increasingly popular and have been found to be beneficial for those who use them. However, there are very few multi-component telemedicine services available for individuals with T1D, and none of them provide a comprehensive technology-based system. Additionally, while these multi-component T1D telemedicine systems often included emerging adults in the group under study, the average age of the study subjects was usually above the age range of emerging adulthood. This suggests that specific developmental needs of emerging adults are not being addressed by these telemedicine systems, nor are the issues faced by diverse populations. More research needs to be done to address which telemedicine services, if any, would be beneficial for this especially vulnerable population.
刚成年的1型糖尿病(T1D)患者经常发现要很好地控制自己的糖尿病很有挑战性,因为他们在这段时间里要处理许多相互竞争的优先事项。大多数新兴成年人(72%)已经在网上寻找健康信息,因此远程医疗可能是与他们一起探索的途径。为T1D患者提供的远程医疗服务正变得越来越受欢迎,并且已被发现对那些使用它们的人有益。然而,针对T1D患者的多组件远程医疗服务很少,而且没有一个提供全面的基于技术的系统。此外,虽然这些多组分T1D远程医疗系统通常在研究组中包括初成人,但研究对象的平均年龄通常高于初成人的年龄范围。这表明,这些远程医疗系统没有解决初生成人的特定发展需求,也没有解决不同人群面临的问题。需要进行更多的研究,以确定哪些远程医疗服务(如果有的话)将对这一特别脆弱的人群有益。
{"title":"Telemedicine Services for Emerging Adults with Type 1 Diabetes","authors":"Neesha Ramchandani","doi":"10.17925/USE.2018.14.2.73","DOIUrl":"https://doi.org/10.17925/USE.2018.14.2.73","url":null,"abstract":"Emerging adults with type 1 diabetes (T1D) often find it challenging to manage their diabetes well due to the many competing priorities they are juggling during this time. The majority of emerging adults (72%) are already looking for health information online, so telemedicine may be an avenue to explore with them. Telemedicine services for individuals with T1D are becoming increasingly popular and have been found to be beneficial for those who use them. However, there are very few multi-component telemedicine services available for individuals with T1D, and none of them provide a comprehensive technology-based system. Additionally, while these multi-component T1D telemedicine systems often included emerging adults in the group under study, the average age of the study subjects was usually above the age range of emerging adulthood. This suggests that specific developmental needs of emerging adults are not being addressed by these telemedicine systems, nor are the issues faced by diverse populations. More research needs to be done to address which telemedicine services, if any, would be beneficial for this especially vulnerable population.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Letter from the Journal 《华尔街日报》的来信
Q4 Medicine Pub Date : 2018-01-01 DOI: 10.17925/USE.2018.14.1.11
M. Marcovecchio
{"title":"Letter from the Journal","authors":"M. Marcovecchio","doi":"10.17925/USE.2018.14.1.11","DOIUrl":"https://doi.org/10.17925/USE.2018.14.1.11","url":null,"abstract":"","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80643268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The New Psychosocial Position Statement from the American Diabetes Association 美国糖尿病协会的新社会心理立场声明
Q4 Medicine Pub Date : 2017-01-01 DOI: 10.17925/USE.2017.13.01.10
L. Siminerio
Received: March 20, 2017 Published Online: May 8, 2017 Citation: US Endocrinology, 2017;13(1):Epub ahead of print Corresponding Author: Linda Siminerio, Professor of Medicine and Nursing, University of Pittsburgh, Falk Medical Building, Room 570, 3601 Fifth Avenue, Pittsburgh PA 15213, US. E: simineriol@upmc.edu D iabetes self-management education and support provides the foundation for helping people with diabetes to be able to navigate decisions and activities related to managing their life-long disease. Here, Linda Siminerio of the School of Medicine and Nursing, University of Pittsburgh, Pennsylvania, US discusses psychological factors affecting people with diabetes, self-management and the multiple benefits of ongoing education and support.
收稿日期:2017年3月20日发布在线日期:2017年5月8日引用来源:美国内分泌学杂志,2017;13(1):Epub预印通讯作者:Linda Siminerio,匹兹堡大学医学与护理学教授,福克医疗大楼,570室,3601 Fifth Avenue, Pittsburgh PA 15213, US。E: simineriol@upmc.edu糖尿病自我管理教育和支持为帮助糖尿病患者能够做出与管理其终生疾病相关的决定和活动提供了基础。在这里,美国宾夕法尼亚州匹兹堡大学医学与护理学院的Linda Siminerio讨论了影响糖尿病患者的心理因素、自我管理以及持续教育和支持的多重好处。
{"title":"The New Psychosocial Position Statement from the American Diabetes Association","authors":"L. Siminerio","doi":"10.17925/USE.2017.13.01.10","DOIUrl":"https://doi.org/10.17925/USE.2017.13.01.10","url":null,"abstract":"Received: March 20, 2017 Published Online: May 8, 2017 Citation: US Endocrinology, 2017;13(1):Epub ahead of print Corresponding Author: Linda Siminerio, Professor of Medicine and Nursing, University of Pittsburgh, Falk Medical Building, Room 570, 3601 Fifth Avenue, Pittsburgh PA 15213, US. E: simineriol@upmc.edu D iabetes self-management education and support provides the foundation for helping people with diabetes to be able to navigate decisions and activities related to managing their life-long disease. Here, Linda Siminerio of the School of Medicine and Nursing, University of Pittsburgh, Pennsylvania, US discusses psychological factors affecting people with diabetes, self-management and the multiple benefits of ongoing education and support.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type 1 Diabetes in Athletes 运动员的1型糖尿病
Q4 Medicine Pub Date : 2017-01-01 DOI: 10.17925/USE.2017.13.02.51
J. Yardley
Managing training and competition with type 1 diabetes is complicated, but not impossible. Athletes, and their diabetes care providers, should be aware of everything that might impact blood glucose responses to exercise. These factors include the type, timing, intensity and duration of exercise, as well as the timing and size of insulin dosage adjustments and carbohydrate intake. Due to differences in physiology (age, sex, fitness levels, etc.) there is no "one size fits all" solution, however, with careful planning and record-keeping, athletes with type 1 diabetes have the same opportunities for success in their sport as everyone else.
管理与1型糖尿病患者的训练和比赛是复杂的,但并非不可能。运动员和他们的糖尿病护理人员应该意识到所有可能影响运动后血糖反应的因素。这些因素包括运动的类型、时间、强度和持续时间,以及胰岛素剂量调整和碳水化合物摄入的时间和大小。由于生理上的差异(年龄、性别、健康水平等),没有“一刀切”的解决方案,然而,通过仔细的计划和记录,患有1型糖尿病的运动员和其他人一样有机会在运动中取得成功。
{"title":"Type 1 Diabetes in Athletes","authors":"J. Yardley","doi":"10.17925/USE.2017.13.02.51","DOIUrl":"https://doi.org/10.17925/USE.2017.13.02.51","url":null,"abstract":"Managing training and competition with type 1 diabetes is complicated, but not impossible. Athletes, and their diabetes care providers, should be aware of everything that might impact blood glucose responses to exercise. These factors include the type, timing, intensity and duration of exercise, as well as the timing and size of insulin dosage adjustments and carbohydrate intake. Due to differences in physiology (age, sex, fitness levels, etc.) there is no \"one size fits all\" solution, however, with careful planning and record-keeping, athletes with type 1 diabetes have the same opportunities for success in their sport as everyone else.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Magnetic Resonance Imaging-guided Focused Ultrasound in Movement Disorders—A Review 磁共振成像引导聚焦超声在运动障碍中的应用综述
Q4 Medicine Pub Date : 2017-01-01 DOI: 10.17925/USE.2017.13.02.74
L. Talman, Binit B. Shah
T he use of surgical treatments for movement disorders has been well established for several decades, with a strong focus, in the past, on ablative lesioning procedures and, more recently, deep brain stimulation. Magnetic resonance imaging (MRI)-guided focused ultrasound (MRgFUS) is emerging as a newly recognized surgical technique for the treatment of various movement disorders. The most robust data, demonstrating safety and efficacy of MRgFUS, have been published in trials directed at treatment of essential tremor (ET); however, many trials are underway to define its role in other movement disorders, such as Parkinson’s disease with preliminary results echoing those from studies in ET. The full potential for use of MRgFUS, both in the field of movement disorders and beyond, is only beginning to be explored.
运动障碍的手术治疗已经有几十年的历史了,过去的重点是烧蚀损伤手术,最近的重点是深部脑刺激。磁共振成像(MRI)引导聚焦超声(MRgFUS)是一种新兴的公认的手术技术,用于治疗各种运动障碍。证明MRgFUS安全性和有效性的最可靠数据已在针对特发性震颤(ET)治疗的试验中发表;然而,许多试验正在进行中,以确定其在其他运动障碍中的作用,如帕金森病,初步结果与ET研究的结果相呼应。MRgFUS在运动障碍和其他领域的全部潜力才刚刚开始探索。
{"title":"The Use of Magnetic Resonance Imaging-guided Focused Ultrasound in Movement Disorders—A Review","authors":"L. Talman, Binit B. Shah","doi":"10.17925/USE.2017.13.02.74","DOIUrl":"https://doi.org/10.17925/USE.2017.13.02.74","url":null,"abstract":"T he use of surgical treatments for movement disorders has been well established for several decades, with a strong focus, in the past, on ablative lesioning procedures and, more recently, deep brain stimulation. Magnetic resonance imaging (MRI)-guided focused ultrasound (MRgFUS) is emerging as a newly recognized surgical technique for the treatment of various movement disorders. The most robust data, demonstrating safety and efficacy of MRgFUS, have been published in trials directed at treatment of essential tremor (ET); however, many trials are underway to define its role in other movement disorders, such as Parkinson’s disease with preliminary results echoing those from studies in ET. The full potential for use of MRgFUS, both in the field of movement disorders and beyond, is only beginning to be explored.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Headache in the Emergency Room 头痛在急诊室
Q4 Medicine Pub Date : 2017-01-01 DOI: 10.17925/USE.2017.13.02.94
Kourosh Kahkeshani, Huma U. Sheikh
{"title":"Headache in the Emergency Room","authors":"Kourosh Kahkeshani, Huma U. Sheikh","doi":"10.17925/USE.2017.13.02.94","DOIUrl":"https://doi.org/10.17925/USE.2017.13.02.94","url":null,"abstract":"","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MC4R Mutation in Early-onset Severe Childhood Obesity—Genotype–phenotype Correlation 早发性重度儿童肥胖的MC4R突变-基因型-表型相关性
Q4 Medicine Pub Date : 2017-01-01 DOI: 10.17925/USE.2017.13.02.69
D. Khandelwal, S. Birla, Arundhati Sharma, R. Khadgawat
M elanocortin-4 receptor (MC4R; OMIM#155541) encodes a 332-amino acids protein possessing typical G-protein-coupled receptors' (GPCRs) structural design having three intact and functional domains, mutations which lead to the most recurrent type of monogenic obesity. Methods: We report here a case of a 5-year-old boy from Iraq who presented to the clinic for evaluation of progressive weight gain since he was 6 months of age. There were no symptoms of hypothalamic dysfunction except increase in appetite. His height was 120 cm (97th centile of the Centers for Disease Control and Prevention [CDC] growth chart, mid parental height was 50th centile), weight was 57 kg (>97th centile on CDC chart) and body mass index was 39.6 kg/m2 (>97th centile on CDC chart). A monogenic cause of obesity was strongly suspected in view of early onset severe childhood obesity. Results: Mutation screening of MC4R revealed a homozygous isoleucine by arginie at codon 69 (I69R) mutation in the patient, while his father was heterozygous for this mutation. Conclusion: We describe a monogenic form of obesity with characteristic presentation due to I69R MC4R mutation inherited as an autosomal recessive condition. The finding is different from previous reports which have documented this mutation to be inherited in a dominant manner. The findings of the present study reiterate the complex nature of obesity with possible involvement of modifier genes and/or genetic heterogeneity in its causation.
M黑素皮质素-4受体;OMIM#155541)编码一种332个氨基酸的蛋白质,具有典型的g蛋白偶联受体(gpcr)结构设计,具有三个完整的功能域,突变导致最常见的单基因肥胖类型。方法:我们在这里报告一个5岁的男孩从伊拉克谁提出了临床评估进行性体重增加,因为他是6个月大。除了食欲增加外,没有下丘脑功能障碍的症状。身高120 cm(美国疾病预防控制中心生长图第97百分位,父母中身高50百分位),体重57 kg(美国疾病预防控制中心生长图第97百分位),体重指数39.6 kg/m2(美国疾病预防控制中心生长图第97百分位)。鉴于早期发病的严重儿童肥胖,人们强烈怀疑肥胖的单基因原因。结果:MC4R基因突变筛查显示患者在密码子69处出现精氨酸异亮氨酸纯合突变(I69R),而其父亲为该突变的杂合突变。结论:我们描述了一种单基因形式的肥胖,其特征性表现是由于I69R MC4R突变遗传为常染色体隐性遗传病。这一发现与以前的报道不同,这些报道记录了这种突变以显性方式遗传。本研究的发现重申了肥胖的复杂性,可能涉及修饰基因和/或遗传异质性。
{"title":"MC4R Mutation in Early-onset Severe Childhood Obesity—Genotype–phenotype Correlation","authors":"D. Khandelwal, S. Birla, Arundhati Sharma, R. Khadgawat","doi":"10.17925/USE.2017.13.02.69","DOIUrl":"https://doi.org/10.17925/USE.2017.13.02.69","url":null,"abstract":"M elanocortin-4 receptor (MC4R; OMIM#155541) encodes a 332-amino acids protein possessing typical G-protein-coupled receptors' (GPCRs) structural design having three intact and functional domains, mutations which lead to the most recurrent type of monogenic obesity. Methods: We report here a case of a 5-year-old boy from Iraq who presented to the clinic for evaluation of progressive weight gain since he was 6 months of age. There were no symptoms of hypothalamic dysfunction except increase in appetite. His height was 120 cm (97th centile of the Centers for Disease Control and Prevention [CDC] growth chart, mid parental height was 50th centile), weight was 57 kg (>97th centile on CDC chart) and body mass index was 39.6 kg/m2 (>97th centile on CDC chart). A monogenic cause of obesity was strongly suspected in view of early onset severe childhood obesity. Results: Mutation screening of MC4R revealed a homozygous isoleucine by arginie at codon 69 (I69R) mutation in the patient, while his father was heterozygous for this mutation. Conclusion: We describe a monogenic form of obesity with characteristic presentation due to I69R MC4R mutation inherited as an autosomal recessive condition. The finding is different from previous reports which have documented this mutation to be inherited in a dominant manner. The findings of the present study reiterate the complex nature of obesity with possible involvement of modifier genes and/or genetic heterogeneity in its causation.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of a Rare Association Between Right Thyroid Hemiagenesis, Lingual Thyroid, and Papillary Thyroid Cancer 右甲状腺功能不全、舌甲状腺与甲状腺乳头状癌罕见相关1例
Q4 Medicine Pub Date : 2017-01-01 DOI: 10.17925/USE.2017.13.01.01
Umal Azmat, J. Phay, T. Teknos, J. Bekeny, F. Nabhan
L ingual thyroid and thyroid hemiagenesis are rare thyroid developmental abnormalities. These conditions can be present with other thyroid diseases, whether functional ones involving abnormal thyroid hormone levels, or structural ones such as presence of thyroid nodules, however the association with thyroid cancer and lingual thyroid or thyroid hemiagenesis is rare. In addition to that, when thyroid hemiagenesis is present, it is usually in the left lobe. We describe here a pregnant patient who presented with metastatic cervical nodes from thyroid cancer who was found on imaging to have right thyroid hemiagenesis. After she underwent an initial surgery for thyroid cancer and metastatic nodal disease, she was then later discovered to have a lingual thyroid. In this case we report this extremely rare combination and also discuss the potential implications of this association on the diagnosis and management of these patients particularly initial surgery and imaging studies needed for the thyroid cancer.
舌性甲状腺和甲状腺功能不全是少见的甲状腺发育异常。这些情况可能与其他甲状腺疾病同时出现,无论是涉及甲状腺激素水平异常的功能性疾病,还是甲状腺结节等结构性疾病,但与甲状腺癌和舌甲状腺或甲状腺功能不全的关联是罕见的。除此之外,当甲状腺功能减退时,通常发生在左叶。我们在这里描述一个孕妇谁提出转移性宫颈淋巴结甲状腺癌谁被发现影像学有右甲状腺功能减退。在她接受了甲状腺癌和转移性淋巴结疾病的初步手术后,她后来被发现患有舌状甲状腺。在这个病例中,我们报告了这种极其罕见的联合,并讨论了这种关联对这些患者的诊断和治疗的潜在影响,特别是甲状腺癌所需的初始手术和影像学研究。
{"title":"A Case of a Rare Association Between Right Thyroid Hemiagenesis, Lingual Thyroid, and Papillary Thyroid Cancer","authors":"Umal Azmat, J. Phay, T. Teknos, J. Bekeny, F. Nabhan","doi":"10.17925/USE.2017.13.01.01","DOIUrl":"https://doi.org/10.17925/USE.2017.13.01.01","url":null,"abstract":"L ingual thyroid and thyroid hemiagenesis are rare thyroid developmental abnormalities. These conditions can be present with other thyroid diseases, whether functional ones involving abnormal thyroid hormone levels, or structural ones such as presence of thyroid nodules, however the association with thyroid cancer and lingual thyroid or thyroid hemiagenesis is rare. In addition to that, when thyroid hemiagenesis is present, it is usually in the left lobe. We describe here a pregnant patient who presented with metastatic cervical nodes from thyroid cancer who was found on imaging to have right thyroid hemiagenesis. After she underwent an initial surgery for thyroid cancer and metastatic nodal disease, she was then later discovered to have a lingual thyroid. In this case we report this extremely rare combination and also discuss the potential implications of this association on the diagnosis and management of these patients particularly initial surgery and imaging studies needed for the thyroid cancer.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67602995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hyperfiltration and Albuminuria—A Deadly Combination 高滤过和蛋白尿是一种致命的组合
Q4 Medicine Pub Date : 2017-01-01 DOI: 10.17925/USE.2017.13.01.12
C. Lardinois
I ndividuals with chronic kidney disease (CKD) are at high risk of coronary heart disease (CHD), and roughly half die of CHD without developing end-stage renal disease. Two key kidney measurements: estimated glomerular filtration rate (eGFR) and albuminuria, are consistently associated with high CHD risk. An eGFR greater than 105 ml/min per 1.73m2 (hyperfiltration) and an albumin-to-creatinine ratio (ACR) greater than 5 mg/g are both independently associated with an increased risk of CHD. Therefore, eGFR and ACR should be taken into account for cardiovascular prediction.
慢性肾脏疾病(CKD)患者是冠心病(CHD)的高危人群,大约一半的人死于冠心病而不会发展为终末期肾脏疾病。两项关键的肾脏测量指标:肾小球滤过率(eGFR)和蛋白尿始终与冠心病高风险相关。eGFR大于105 ml/min / 1.73m2(高滤过)和白蛋白/肌酐比(ACR)大于5 mg/g均与冠心病风险增加独立相关。因此,在预测心血管疾病时应考虑eGFR和ACR。
{"title":"Hyperfiltration and Albuminuria—A Deadly Combination","authors":"C. Lardinois","doi":"10.17925/USE.2017.13.01.12","DOIUrl":"https://doi.org/10.17925/USE.2017.13.01.12","url":null,"abstract":"I ndividuals with chronic kidney disease (CKD) are at high risk of coronary heart disease (CHD), and roughly half die of CHD without developing end-stage renal disease. Two key kidney measurements: estimated glomerular filtration rate (eGFR) and albuminuria, are consistently associated with high CHD risk. An eGFR greater than 105 ml/min per 1.73m2 (hyperfiltration) and an albumin-to-creatinine ratio (ACR) greater than 5 mg/g are both independently associated with an increased risk of CHD. Therefore, eGFR and ACR should be taken into account for cardiovascular prediction.","PeriodicalId":23490,"journal":{"name":"US endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67603054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
US endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1